Philadelphia Urosurgical Associates

Philadelphia Urosurgical Associates was a specialized medical practice and clinical research center located in Philadelphia, Pennsylvania, primarily associated with the Hahnemann University Hospital complex. Led by Dr. Kristene Whitmore, a renowned expert in urology and urogynecology, the practice focused on the treatment of complex pelvic and bladder conditions, including interstitial cystitis and bladder pain syndrome. The center was a significant site for clinical research, sponsoring and conducting trials for therapies such as Botox and Myrbetriq in collaboration with major pharmaceutical companies like Astellas and Allergan. Following the closure of Hahnemann University Hospital in 2019, the practice's operations were impacted, and its leadership transitioned to other regional health systems. The entity is recognized for its contributions to pelvic floor research and the evaluation of pharmacological treatments for chronic urological pain.